On-Demand Webinar: Cost-Effectiveness Analysis with R? A Discussion

Are you involved in preparing health technology assessment (HTA) submissions and in early health economic modeling as part of drug development decision-making? You won't want to miss our webinar, "Cost-Effectiveness Analysis with R? A Discussion." Learn about the pros and cons of R versus Excel in preparing HTA submissions, and the acceptability of R by HTA agencies.

LEARN MORE

On-Demand Webinar: Cost-Effectiveness Analysis with R? A Discussion2021-12-15T13:22:25-05:00

PRECISIONheor Executive Summary: NICE-UK Strategy 2021-2026

Recently, the National Institute for Health and Care Excellence (NICE) published a detailed strategy plan, outlining its vision during the next five years. Included in this report are new guidelines for technology evaluation, evidence standards, guidance adoption, and real-world data and research, which are applicable to all stakeholders, including the life science industry, regulators, healthcare providers, patients, and the public.

LEARN MORE

PRECISIONheor Executive Summary: NICE-UK Strategy 2021-20262021-11-11T11:01:03-05:00